Can We Efficiently Target HDAC in Cancer?

Tobias Kiesslich; Daniel Neureiter

doi:10.3390/cancers14164058

Can We Efficiently Target HDAC in Cancer?

Tobias Kiesslich (Erstautor/-in)
, Daniel Neureiter^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Editorial › Begutachtung

4 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Cancers
Jahrgang	14
Ausgabenummer	16
DOIs	https://doi.org/10.3390/cancers14164058
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.3390/cancers14164058

Dieses zitieren

@article{8291e9d7a4fb406994f0a6a12ff46e8f,

title = "Can We Efficiently Target HDAC in Cancer?",

keywords = "HALLMARKS",

author = "Tobias Kiesslich and Daniel Neureiter",

note = "Kiesslich, T; Neureiter, D;: Center for Physiology, Pathophysiology and Biophysics-Salzburg and Nuremberg, Institute for Physiology and Pathophysiology-Salzburg, Paracelsus Medical University, Strubergasse 22, 5020 Salzburg, Austria***Department of Internal Medicine I, University Clinics Salzburg, Paracelsus Medical University, M{\"u}llner Hauptstrasse 48, 5020 Salzburg, Austria***Institute of Pathology, University Clinics Salzburg, Paracelsus Medical University, M{\"u}llner Hauptstrasse 48, 5020 Salzburg, Austria***Cancer Cluster Salzburg, 5020 Salzburg, Austria ",

year = "2022",

doi = "10.3390/cancers14164058",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",